US 11786542
Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways
granted A61KA61K31/343A61K31/495
Quick answer
US patent 11786542 (Methods for enhancing cytotoxic cancer therapy through modulation of purine biosynthesis pathways) held by Northwestern University expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/343, A61K31/495, A61K31/7056